PRKCA and rheumatoid arthritis: Together, these findings indicated that Hint1, ACP1, FGR, HSP90@157W + oxidation, and Prkca@220N + 845.4540 Da acted as the key targets of S. tetrandra, which showed therapeutic effects on RA by inhibiting the PI3K/Akt pathway.